MM+M Roundtable Highlights the Benefits of Virtual Agents for Pharma Brands
Artificial Intelligence (AI) can create a meaningful impact on customer engagement in the pharmaceutical and life sciences industries, with virtual agents emerging as a powerful tool for patient interaction and data collection. These agents offer personalized experiences and real-time support throughout the patient journey. Despite their potential, over 72% of pharma marketers currently lack a dedicated budget for this solution, indicating a significant opportunity for growth and innovation in this space.
At a recent MM+M roundtable, leaders in the industry gathered to discuss the benefits and challenges of integrating AI virtual agents into pharma marketing strategies. These intelligent systems can enhance the analysis of voice-of-the-customer (VOC) data and website analytics, providing valuable insights into patient needs and preferences.
From gathering real-time data to inform marketing strategies to improving the overall patient experience, AI-powered virtual agents can help personalize customer interactions. Yet, many brands struggle with monitoring these tools, and evolving data and privacy regulations further complicates engagement.
